Trials / Sponsors / Sichuan Clover Biopharmaceuticals, Inc.
Sichuan Clover Biopharmaceuticals, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Clinical Trial Evaluating SCB-219M in in Chemotherapy-induced Thrombocytopenia (CIT) Chemotherapy-induced Thrombocytopenia (CIT) | Phase 1 | 2022-06-14 |
| Completed | A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Maligna Malignant Pleural Effusion | Phase 1 | 2020-01-08 |
| Completed | Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites Malignant Ascites | Phase 1 | 2019-09-28 |
| Terminated | A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis Peritoneal Carcinomatosis | Phase 1 | 2019-09-10 |